Summary
Overview
Work History
Education
Skills
Websites
Certification
Acknowledgements
Publications Posters And Presentations
Timeline
Generic

Joseph McLaughlin

San Diego

Summary

Dynamic Senior Associate Scientist with extensive experience in CNS and oncology pharmacology. Expert in in vivo study design and rodent behavior analysis, successfully executing complex pharmacokinetic studies. Proven ability to present data effectively and collaborate within teams, driving impactful research outcomes in preclinical settings.

Overview

29
29
years of professional experience
1
1
Certification

Work History

Senior Associate Scientist, Oncology Pharmacology

Vividion Therapeutics
San Diego
11.2021 - Current
  • Executed pharmacokinetic/pharmacodynamic and target engagement studies to support pre-clinical programs.
  • Administered small molecule compounds to mice via multiple routes(PO, SC, IP, IV, IT); measured endpoints and collected samples for analysis.
  • Conducted in vitro cell culture experiments as required by research protocols.
  • Performed ELISA, imaging, and clinical chemistry to analyze biological samples.
  • Collaborated effectively within pharmacology team while also working independently on projects.
  • Collected and organized scientific data for presentation in project team meetings.
  • Presented technical findings internally to ensure alignment with project goals.

Senior Research Associate – In Vivo Pharmacology

Novartis Gene Therapy
San Diego
01.2021 - 11.2021
  • Deliver in vivo assistance to gene therapy programs, which involves administering doses to animals, conducting surgeries, performing behavioral assays, and executing necropsies.

Senior Research Associate II – NS Biology

Takeda Pharmaceuticals
San Diego
08.2017 - 01.2021
  • Developed and validated cognition assays, including Novel Object Recognition and Barnes Maze, to evaluate CNS compounds.
  • Validated DOI-elicited Head Twitch Response and Rodent Hot Plate as pharmacodynamics screening assays for multiple projects.
  • Conducted in vivo pharmacokinetic/pharmacodynamic studies on satellite animals.
  • Trained interns and contractors in animal handling, dosing, and tissue harvesting practices.
  • Received 2018 Neuroscience DDU Award for contributions to patient-pipeline initiatives.
  • Served as CNS Representative on Vivarium Users Committee, advocating for best practices.

Senior Research Associate-Pharmacology and Translational Research

Nektar Therapeutics
San Francisco
01.2014 - 08.2017
  • Conducted experiments to support preclinical pharmacology for clinical candidates in oncology, pain, and neuropsychiatric disorders.
  • Prepared growth media, performed tissue culture, and applied sterile techniques for research.
  • Executed tumor cell harvest and implantation procedures, monitoring tumor measurements throughout studies.
  • Administered test materials via various routes while maintaining rigorous documentation of results.
  • Consolidated data and summarized observations from studies for comprehensive analysis.
  • Assisted in developing an osteoarthritis model to enhance research capabilities.
  • Led hematology team, ensuring adherence to project timelines and quality standards.

Senior Research Associate-Pharmacology

Hydra Biosciences
Cambridge
08.2012 - 12.2013
  • Validated and maintained rodent models of depression, anxiety, and pain using multiple behavioral tests.
  • Collected, analyzed, and summarized experimental data for accurate documentation.
  • Supported pain and inflammation assays through surgical procedures, dosing, and sample acquisition.
  • Utilized forced swim test, marble burying, and elevated plus maze for behavioral analysis.
  • Performed Von Frey tests to measure rodent pain response.
  • Conducted manual and automated gait analysis for comprehensive assessments.

Colony Manager

Alphagenesis, Inc
Yemassee
09.2010 - 08.2012
  • Executed initial diagnosis and preliminary treatment for nonhuman primates.
  • Performed blood collection, dosing via oral, IV, SC, and IM routes.

Senior Associate Scientist, Behavioral Pharmacology

AstraZeneca Pharmaceuticals
Wilmington
06.2006 - 08.2010
  • Maintained rodent behavioral models for depression and anxiety, including forced swim test and locomotor activity.
  • Operated and maintained laboratory equipment with technical proficiency.
  • Documented experimental results through data collection, analysis, and summarization.
  • Provided information on anxiolytic effects of lead compounds via punished responding assay.
  • Delivered target validation data for early-stage projects focused on stress-related disorders.
  • Developed and maintained assays for set shifting, reversal, and mydriasis.
  • Received Extra Mile Award in 2007 and 2009.

Laboratory Animal Associate, Laboratory Animal Resources

Merck and Company
West Point
06.2005 - 05.2006
  • Implemented comprehensive veterinary medical program encompassing medical treatment and surgical procedures.
  • Provided study support for research cores involving primates, dogs, rabbits, rats, mice, and cotton rats.
  • Executed sentinel sampling to maintain colony health and monitor well-being.

Research Specialist, Nonhuman Research Program, Gene Therapy Program

University of Pennsylvania
Philadelphia
03.2002 - 05.2005
  • Coordinated nonhuman primate research studies and provided essential technical support.
  • Ensured proper collection of blood and clinical chemistry materials during necropsies and in-life phases.
  • Acted as liaison between personnel and biomedical research cores for sample management.
  • Managed nonhuman primate studies at external facilities to enhance research capabilities.

Technician, Veterinary Medicine

H.L. Yoh (Contractor at AstraZeneca)
Wilmington
01.2000 - 02.2002
  • Managed husbandry, delivery, observations, dosing, sample collection, and environmental enrichment for nonhuman primates, rats, mice, guinea pigs, and gerbils.

Unit Manager, Clinical Veterinary Medicine

LABS of Virginia
Yemassee
01.1997 - 01.2000
  • Executed initial diagnosis and preliminary treatment, including capture and restraint procedures.
  • Administered medical treatments and maintained comprehensive treatment records.
  • Performed minor surgical procedures, pre-operative and post-operative care.
  • Conducted diagnostic laboratory procedures, blood collection, and TB testing with grading.
  • Delivered neonatal and minor obstetrical care alongside various dental procedures.
  • Isolated SRV+ monkeys to effectively remove SRV from breeding populations.
  • Supervised and trained on-site technicians and interns, ensuring operational efficiency.

Education

Target Identification, Validation, and Screening -

UCSD Extension
San Diego, CA
01-2022

Pharmacokinetics -

UCSD Extension
San Diego, CA
01-2019

Artium Baccalaureatus - Anthropology

College of Charleston
Charleston, SC

Skills

  • In vivo study design
  • Animal handling techniques
  • Rodent behavior analysis
  • Oncology testing methodologies
  • Imaging techniques
  • Data analysis and presentation
  • ELISA procedures

Certification

  • LATG, AALAS
  • Purina Lab Diet Lab Animal Care Course
  • Applied Primatology, SUNY Delhi
  • Handling and Care of the Laboratory Non-human Primate, UPENN
  • Online Mini Courses, JAX
  • Cancer Biology Certification, Johns Hopkins University
  • History of Medicine: Philosophy, Science and Psychology, Johns Hopkins University

Acknowledgements

  • Biology of AAV Serotype Vectors in Liver-Directed Gene Transfer to Nonhuman Primates., Guangping Gao, You Lu, Roberto Calcedo, Rebecca L. Grant, Peter Bell, Lili Wang, Joanita Figueredo, Martin Lock and James M. Wilson., Molecular Therapy, 2006
  • Nonhuman Primate Models for Diabetic Ocular Neovascularization Using AAV2-Mediated Overexpression of Vascular Endothelial Growth Factor., Corinna Lebherz, Albert M. Maguire, Alberto Auricchio, Waixing Tang, Tomas S. Aleman, Zhangyong Wei, Rebecca Grant, Artur V. Cideciyan, Samuel G. Jacobson, James M. Wilson, Jean Bennett., Diabetes, 2005
  • Long-Term Inducible Gene Expression in the Eye via Adeno-Associated Virus Gene Transfer in Nonhuman Primates., Corinna Lebherz, Alberto Auricchio, Albert M. Maguire, Victor M. Rivera, Waixing Tang, Rebecca L. Grant, Tim Clackson, Jean Bennett, James M. Wilson., Human Gene Therapy, 2005

Publications Posters And Presentations

  • Development of a Dry Blood Spot Assay for Rodent Neurofilament Light to Better Enable Longitudinal Studies in Neurodegenerative Animal Models., Katherine Lundeen, Faizan Zubair, Megan Turski, Mark Claudio, Anne Kanta, Anthony Munday, Joseph McLaughlin, Nicola Broadbent, Paul Rolzin, Andrea Green, Inigo Narvaiza, Mike Zientek, Natalie Hosea., 2022
  • Method Development for a Brain Neprilysin Enzymatic Activity Assay: Validation in Two Rodent Models of Cognition., Katherine Lundeen, Anne T. Kanta, Joseph McLaughlin, Daniela Radl, Erica L. Bradshaw-Pierce, Melinda Manuel., 2018
  • Harnessing the innate and adaptive immune system to eradicate treated and distant untreated solid tumors., Saul Kivimae, Werner Rubas, Rhoneil Pena, Joseph McLaughlin, Marlene Hennessy, Yolanda Kirksey, Wildaliz Nieves, Myong Lee, Clive Law, Kavitha Bhasi, Phi Quach, Janet Cetz, John L. Langowski, Christie Fanton, Jose Zandro Aquino, Zhonxu Ren, Halying Cai, BoLiang Deng, Wen Zhang, Neel K. Anand, Jennifer A. Riggs-Sauthier, Steve Doberstein, Jonathan Zalevsky., Society for Immunotherapy in Cancer (SITC) 32nd Annual Meeting, National Harbor, MD, 2018
  • Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice., Stefan Just, Bertrand L. Chenard, Angelo Ceci, Timothy Strassmaier, Jayhong A. Chong, Nathaniel T. Blair, Randall J. Gallaschun, Donato del Camino, Susan Cantin, David P. Hessler, Bastain Hengerer, Katja S. Kroker, Sam Malekiani, Robert Mihalek, Joseph McLaughlin, JoAnn Witek, Achim Sauer, Christopher Pryce, Magdalene M. Moran., 2018
  • Discovery of 3-(3,4-Dichlorophenyl)-2,3,4,7-tetrahydro-1H-azepines and related analogs as Potent Norepinephrine and Dopamine Dual Uptake Inhibitors with Efficacy in Animal Model of Depression., 2013
  • Effects of the Delta Opiod Agonist AZD2327 in Tests for Anxiolytic and Antidepressant Activity., Carla Maciag, Shuang Li, Mark Pietras, Jin Zhou, Joe McLaughlin, Linda Litwin, Carolann Thompson, Jennifer Werkheiser and TJ Hudzik., Society for Neuroscience, 2011
  • Effects of prenatal stress and chronic antidepressant treatment on brain and plasma BDNF in rats., Li S, Piser T, Smith M, Hudzik T, Maciag C, Thompson C, McLaughlin J, Brockel B., Society for Neuroscience, Chicago, IL, 2009
  • Preclinical Characterization of Antidepressant Effect of Norquetiapine: Role of the Norepinephrine Transporter in Preclinical Depression Models., Zhou, Jin, McLaughlin, Joe, Zacco, Anna, Hudzik, Thomas, Zeller, Zeke, Brockel, Becky, Litwin, Linda, Li, Shuang, Werkheiser, Jennifer, Jiang, Qiaoling, Lazor, Lois A., Gunyuzlu, Paul, Largent, Brian, Yocca, Frank, Widzowski, Dan., Biological Psychiatry, 2009
  • Comparison of antidepressant and anxiolytic activity of quetiapine and its metabolite, norquetiapine, in rodent models., Maciag, C., Brockel, B., Smolka, J., McLaughlin, J., Duncan, B., Evenden, J., Hudzik, T., Widzowski, D., International Journal of Neuropsychopharmacology, 2008
  • Anxiolytic Effects of Quetiapine in Rat Punished Responding: Mechanism of Action and the Role of D2 Antagonism., C. Maciag, J. Smolka, J. McLaughlin, T. Hudzik, J. Evenden, D. Widzowski., European Neuropsychopharmacology, 2007
  • Differences in Blood Values of Chinese and Indian Origin Rhesus Macaques., J. McLaughlin, B. Murphy, P. McLaughlin., DVB AALAS, 2004
  • Physical and Behavioral Phenotypic Differences Identified in Male Mice Carrying the Amyloid Precursor Protein Transgene (Tg#2576) and Their Same Sex Nontransgenic Siblings., T. M. McLaughlin, J. McLaughlin, D. Baker., Capitol Branch AALAS, 2003
  • Imipramine Reverses Long-lasting Deficits in Impulse Control Following Fimbria-fornix Lesions., C. Maciag, J. McLaughlin, D. Maier, T. Ko, T.J. Hudzik., Society for Neuroscience Abstract Viewer & Itinerary Planner, 2002
  • Characterization of Behavioral Effects Following Fimbria-Fornix Lesion for Drug Discovery of Cognitive Enhancers., C. Maciag, J. McLaughlin, D. Maier, B. Cross, D. Widzowski., Society for Neuroscience Abstracts, 2001
  • Diarrhea Management in Non-Human Primates., J. McLaughlin., SEAALAS, 1999

Timeline

Senior Associate Scientist, Oncology Pharmacology

Vividion Therapeutics
11.2021 - Current

Senior Research Associate – In Vivo Pharmacology

Novartis Gene Therapy
01.2021 - 11.2021

Senior Research Associate II – NS Biology

Takeda Pharmaceuticals
08.2017 - 01.2021

Senior Research Associate-Pharmacology and Translational Research

Nektar Therapeutics
01.2014 - 08.2017

Senior Research Associate-Pharmacology

Hydra Biosciences
08.2012 - 12.2013

Colony Manager

Alphagenesis, Inc
09.2010 - 08.2012

Senior Associate Scientist, Behavioral Pharmacology

AstraZeneca Pharmaceuticals
06.2006 - 08.2010

Laboratory Animal Associate, Laboratory Animal Resources

Merck and Company
06.2005 - 05.2006

Research Specialist, Nonhuman Research Program, Gene Therapy Program

University of Pennsylvania
03.2002 - 05.2005

Technician, Veterinary Medicine

H.L. Yoh (Contractor at AstraZeneca)
01.2000 - 02.2002

Unit Manager, Clinical Veterinary Medicine

LABS of Virginia
01.1997 - 01.2000

Target Identification, Validation, and Screening -

UCSD Extension

Pharmacokinetics -

UCSD Extension

Artium Baccalaureatus - Anthropology

College of Charleston
Joseph McLaughlin
Want your own profile? Build for free at Resume-Now.com